Bixiye
QP31-21 Update for New to Market Medical Drugs: Avalglucosidase Alfa and Selexipag (Uptravi intravenous formulation)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Natiijooyinka Raadinta
Soo bandhiga 1651 - 1660 ee natiijooyinka 4296
Bixiye
QP28-21 Commercial Pharmacy Benefit Exclusion for Select Medications and Formulary Alternatives
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP70-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective November 1, 2021
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 08, 2021
Bixiye
QP65R1-21 Update: Minnesota Health Care Programs Providers use of the Interactive Care Reviewer
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 08, 2021
Bixiye
QP69-21 Update for New to Market Medical Drugs: Ciltacabtagene Autoleucel
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 08, 2021
Bixiye
2021 September Bulletins
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2021
Bixiye
P49-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2021
Bixiye
P51-21 eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2021